In a recently released analyst research report, Cowen & Co. Managing Director and Senior Research Analyst covering beverages, tobacco, and cannabis, Vivien Azer, reiterated her buy rating on shares of Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB) (FRA:21P) with a price target that suggests some noteworthy upside to come.
This update to analyst guidance comes just a few days after Aurora Cannabis announced its plans for the highly-anticipated expansion of the consumer cannabis market into vapes, concentrates, and edibles.
Vivien Azer’s price target of $15.00 CAD per share implies a potential upside of approximately 56.90% based on the last traded price of $9.56 CAD per share on the TSX.
According to TheFly, “Cowen analyst Vivien Azer said Aurora Cannabis remains her Top Pick in cannabis. She said as the company continues to ramp up supply, it is establishing an even stronger leadership position in both capacity and profitability with a target to be EBITDA positive in the current fiscal quarter. Azer reiterated her Outperform rating and C$15 price target on Aurora Cannabis shares.”
Be sure to subscribe to updates here so you never miss an important development.
Get Real-Time Updates from MJobserver.com